Sex-Driven Differences in the Effectiveness of Individualized Clinical Management of Alzheimer’s Disease Risk

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
2426-0266
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
Sex-Driven Differences in the Effectiveness of Individualized Clinical Management of Alzheimer’s Disease Risk ; day:26 ; month:4 ; year:2022 ; pages:1-12
The journal of prevention of Alzheimer's disease ; (26.4.2022), 1-12

Urheber
Saif, N.
Hristov, H.
Akiyoshi, K.
Niotis, K.
Ariza, I. E.
Malviya, N.
Lee, P.
Melendez, J.
Sadek, G.
Hackett, K.
Rahman, A.
Meléndez-Cabrero, J.
Greer, C. E.
Mosconi, L.
Krikorian, R.
Isaacson, Richard S.
Beteiligte Personen und Organisationen
SpringerLink (Online service)

DOI
10.14283/jpad.2022.44
URN
urn:nbn:de:101:1-2022070719023792279522
Rechteinformation
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
15.08.2025, 07:36 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.

Objekt beim Datenpartner anzeigen

Beteiligte

  • Saif, N.
  • Hristov, H.
  • Akiyoshi, K.
  • Niotis, K.
  • Ariza, I. E.
  • Malviya, N.
  • Lee, P.
  • Melendez, J.
  • Sadek, G.
  • Hackett, K.
  • Rahman, A.
  • Meléndez-Cabrero, J.
  • Greer, C. E.
  • Mosconi, L.
  • Krikorian, R.
  • Isaacson, Richard S.
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Tracking neuroinflammatory biomarkers in Alzheimer’s disease: a strategy for individualized therapeutic approaches?

Tracking neuroinflammatory biomarkers in Alzheimer’s disease: a strategy for individualized therapeutic approaches?

Sex-specific DNA methylation differences in Alzheimer’s disease pathology

Sex-specific DNA methylation differences in Alzheimer’s disease pathology

Distinct sex-specific DNA methylation differences in Alzheimer’s disease

Distinct sex-specific DNA methylation differences in Alzheimer’s disease

Alzheimer’s disease-related transcriptional sex differences in myeloid cells

Alzheimer’s disease-related transcriptional sex differences in myeloid cells

Data-driven FDG-PET subtypes of Alzheimer’s disease-related neurodegeneration

Data-driven FDG-PET subtypes of Alzheimer’s disease-related neurodegeneration

Early and late-onset Alzheimer’s disease: What are the differences?

Early and late-onset Alzheimer’s disease: What are the differences?

Alzheimer’s Disease

Alzheimer’s Disease

Network-driven plasma proteomics expose molecular changes in the Alzheimer’s brain

Network-driven plasma proteomics expose molecular changes in the Alzheimer’s brain

Interpretable machine learning-driven biomarker identification and validation for Alzheimer’s disease

Interpretable machine learning-driven biomarker identification and validation for Alzheimer’s disease

Sex and age interact to determine clinicopathologic differences in Alzheimer’s disease

Sex and age interact to determine clinicopathologic differences in Alzheimer’s disease

Cost-effectiveness of cerebrospinal biomarkers for the diagnosis of Alzheimer’s disease

Cost-effectiveness of cerebrospinal biomarkers for the diagnosis of Alzheimer’s disease

Increased CSF-decorin predicts brain pathological changes driven by Alzheimer’s Aβ amyloidosis

Increased CSF-decorin predicts brain pathological changes driven by Alzheimer’s Aβ amyloidosis

Verbundene Objekte